In contrast, the association of MAPK12—a gene encoding a stress‐responsive kinase—with poor prognosis suggests a potential role in tumor migration, invasion, and perhaps treatment resistance, mechanisms that are distinct from those of canonical biomarkers [49]. The gene discussed is MAPK12; the disease is neoplasm.